Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) EV-to-EBIT : 37.19 (As of May. 13, 2025)

Chunghwa Chemical Synthesis & Biotech Co EV-to-EBIT Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-EBIT		Get a 7-Day Free Trial					7.06	11.16	9.09	15.28	41.59

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-EBIT	Get a 7-Day Free Trial															15.28	28.28	30.40	30.47	41.59

Competitive Comparison of Chunghwa Chemical Synthesis & Biotech Co's EV-to-EBIT

For the Biotechnology subindustry, Chunghwa Chemical Synthesis & Biotech Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chunghwa Chemical Synthesis & Biotech Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chunghwa Chemical Synthesis & Biotech Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Chunghwa Chemical Synthesis & Biotech Co's EV-to-EBIT falls into.

Chunghwa Chemical Synthesis & Biotech Co EV-to-EBIT Calculation

Chunghwa Chemical Synthesis & Biotech Co's EV-to-EBIT for today is calculated as:

Chunghwa Chemical Synthesis & Biotech Co's current Enterprise Value is NT$2,920 Mil.
Chunghwa Chemical Synthesis & Biotech Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chunghwa Chemical Synthesis & Biotech Co  (TPE:1762) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Chunghwa Chemical Synthesis & Biotech Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Chunghwa Chemical Synthesis & Biotech Co's Enterprise Value for the quarter that ended in Dec. 2024 was NT$3,265 Mil.
Chunghwa Chemical Synthesis & Biotech Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chunghwa Chemical Synthesis & Biotech Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Chunghwa Chemical Synthesis & Biotech Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Chunghwa Chemical Synthesis & Biotech Co Business Description